BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen JY, Liu LP, Xu JF. Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy. Onco Targets Ther. 2017;10:339-345. [PMID: 28138257 DOI: 10.2147/ott.s125250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Tian YL, Ji JJ, Chen LN, Cui XL, Liu ST, Mao L, Qiu YD, Li BB. Risk factors for long-term prognosis of hepatocellular carcinoma patients after anatomic hepatectomy. World J Clin Cases 2020; 8(4): 713-722 [PMID: 32149055 DOI: 10.12998/wjcc.v8.i4.713] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Wang H, Chan TW, Vashisht AA, Drew BG, Calkin AC, Harris TE, Wohlschlegel JA, Xiao X, Reue K. Lipin 1 modulates mRNA splicing during fasting adaptation in liver. JCI Insight 2021;6:150114. [PMID: 34494556 DOI: 10.1172/jci.insight.150114] [Reference Citation Analysis]
3 Zhang Y, Yong H, Fu J, Gao G, Shi H, Zhou X, Fu M. miR-504 Promoted Gastric Cancer Cell Proliferation and Inhibited Cell Apoptosis by Targeting RBM4. J Immunol Res 2021;2021:5555950. [PMID: 34195294 DOI: 10.1155/2021/5555950] [Reference Citation Analysis]